A new pill for sleep apnea could offer hope for those struggling with CPAP machines, according to leading researchers.

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Maryland Medicaid recipients under the Johns Hopkins insurance plan Priority Partners have a new resource. Aeroflow Health, a ...

Maryland Medicaid recipients under the Johns Hopkins insurance plan Priority Partners have a new resource. Aeroflow Health, a ...

It’s estimated eight million people in the UK have sleep apnoea, which causes breathing to repeatedly stop and start ...

The NHS is set to trial a new device, the "Zeus Sleep device", which could help the estimated eight million people in the UK suffering from sleep apnoea.

The Minister for Health and Active Ageing, Jo Etienne Abela, inaugurated the new Cardio-Respiratory Department at the Gozo General Hospital. Through an investment of €500,000, services are ...

By Byron Kaye SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight ...

New Life Center now has 184 beds for men.

ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...